Table 2 Infection agents according to coinfection regions in COVID-19 cases monitored in an intensive care unit
From: Are bacterial coinfections really rare in COVID-19 intensive care units?
Infection type, agent | n (%) | Episode |
|---|---|---|
Pulmonary | 85 | 109 |
Acinetobacter spp. | 52 (61) | |
E. coli | 6 (7) | |
Klebsiella pneumoniae | 11 (13) | |
Pseudomonas spp. | 9 (11) | |
MRSA | 7 (8) | |
Staphylococcus epidermidis | 1 (1) | |
MRSE | 4 (5) | |
Enterococcus spp. | 18 (21) | |
Proteus spp. | 1 (1) | |
Blood | 48 | 58 |
Acinetobacter spp. | 22 (46) | |
E. coli | 4 (8) | |
Klebsiella pneumoniae | 6 (13) | |
Pseudomonas spp. | 5 (10) | |
MRSA | 6 (13) | |
Staphylococcus epidermidis | 4 (8) | |
MRSE | 6 (13) | |
Enterococcus spp. | 6 (13) | |
Catheter | 6 | 10 |
Acinetobacter spp. | 4 (67) | |
E. coli | 2 (33) | |
Klebsiella pneumoniae | 1 (17) | |
MRSA | 28 (33) | |
Enterococcus spp. | 1 (17) | |
Urinary | 33 | 45 |
Acinetobacter spp. | 11 (33) | |
E. coli. | 9 (27) | |
Klebsiella pneumoniae | 7 (21) | |
Pseudomonas spp. | 2 (6) | |
MRSA | 1 (3) | |
Staphylococcus epidermidis | 1 (3) | |
MRSE | 4 (12) | |
Enterococcus spp. | 9 (27) | |
Proteus spp. | 1 (3) |